Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Emerging Biotech & Pharma Index: 36 More Cos.
Nov 24, 2008 01:40 AM
- Full Calendar On Tap for FDA Through Year-End
Nov 13, 2008 06:23 PM
- 3SBio: Solid Q3 Results - Analyst Blog
Nov 13, 2008 05:21 PM
- Amag Pharma a Magnificent Buy - Analyst Blog
Nov 04, 2008 12:48 PM
- Amag Pharma with Huge Upside - Analyst Blog
Oct 16, 2008 12:37 PM
- Analyst Comments: SMI, Gushan, Priceline, ArthroCare, ZOLL Medical, Orchid Cellmark, Charlotte Russe, Hoku Scientific, 3SBio, Skechers, Coca-Cola Hellenic
Oct 07, 2008 02:22 PM
- Periodicals Wrap-Up for Thursday, July 10th
Jul 10, 2008 09:35 AM
- Featured Company: Is 3SBio Too Conservative?
Jul 01, 2008 09:34 PM
- Good Entry Point for Amag Pharma
Jul 01, 2008 12:30 PM
- AMAG Pharma: Actionable Call Alert!
Jun 02, 2008 09:56 AM
- Zacks Analyst Blog Highlights: BJ's Wholesale Club, Inc., Stone EnergyCorp., NetEase.Com Inc., Nordstrom Inc. And 3SBio Inc.
Nov 17, 2008 11:53 PM
- AMAG Pharmaceuticals Announces Ferumoxytol Resubmission Designated Complete, Class 1 Response by the FDA
Nov 13, 2008 08:38 AM
- AMAG Pharmaceuticals, Inc. to Present at the Deutsche Bank 2008 Biotech Boston Confab
Nov 05, 2008 09:00 AM
- Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals, Overstock.Com, Humana, TC PipeLines and Smith Micro
Nov 05, 2008 06:51 AM
- AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter Ended September 30, 2008
Nov 03, 2008 04:06 PM
- AMAG Pharmaceuticals, Inc. to Host Conference Call on November 3, 2008 to Discuss Financial Results for the Quarter Ended September 30, 2008
Oct 28, 2008 05:40 PM
- AMAG Pharmaceuticals Receives Complete Response Letter from FDA for Ferumoxytol
Oct 20, 2008 07:06 AM
- AMAG Pharmaceuticals, Inc. to Present at Two Upcoming Investor Conferences
Aug 27, 2008 09:07 AM
- AMAG Pharmaceuticals Receives Fast Track Designation for Ferumoxytol for Vascular-Enhanced Magnetic Resonance Imaging
Aug 21, 2008 12:39 PM
- AMAG Pharmaceuticals, Inc. to Present at the Canaccord Adams 28th Annual Global Growth Conference
Jul 31, 2008 04:35 PM
- Form 4 AMAG PHARMACEUTICALS For: Aug 05 Filed by: Arkowitz David (10K)
Aug 07, 2008 06:03 PM
- Form 4 AMAG PHARMACEUTICALS For: Aug 05 Filed by: ALLEN LEE F MD PhD (10K)
Aug 07, 2008 06:03 PM
- Form 4 AMAG PHARMACEUTICALS For: Aug 05 Filed by: LEWIS JEROME M (10K)
Aug 07, 2008 06:03 PM
- Form 4 AMAG PHARMACEUTICALS For: Aug 05 Filed by: Healey Timothy G (10K)
Aug 07, 2008 06:03 PM
- Form 4 AMAG PHARMACEUTICALS For: Aug 05 Filed by: NARACHI MICHAEL (10K)
Aug 07, 2008 06:02 PM
- Form 4 AMAG PHARMACEUTICALS For: Aug 05 Filed by: Pereira Brian JG (10K)
Aug 07, 2008 06:02 PM
- Form 4 LEWIS JEROME M For: Jul 31 (10K)
Aug 01, 2008 06:02 PM
- Form 4 AMAG PHARMACEUTICALS For: Jun 11 Filed by: Arkowitz David (10K)
Jun 13, 2008 09:44 AM
- Form 4 AMAG PHARMACEUTICALS For: Jun 09 Filed by: ZWANZIGER RON (10K)
Jun 10, 2008 05:02 PM
- Form 4 AMAG PHARMACEUTICALS For: Jun 02 Filed by: Arkowitz David (10K)
Jun 04, 2008 05:04 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
AMAG
|
Compare to S&P
|
| YTD |
-43.99 %
|
-8.23 %
|
| 4 Weeks |
10.14 %
|
19.05 %
|
| 12 Weeks |
-14.32 %
|
18.76 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -39.00 %
|
|
EPS Growth in Last Year: -230.95 %
|
|
Sales Growth in Last Quarter: -46.50 %
|
|
Sales Growth in Last Quarter: -48.31 %
|
|
|
